France Biotechnology & Medical Research

Genoway SA (ALGEN)

Track

Over the past 90 days, Genoway SA recorded 7 insider trading transactions. Insiders executed purchases totaling 161,981.6 EUR, primarily driven by CEO Alexandre Fraichard, while sales amounted to 57,153.6 EUR, largely involving board members. The stock has seen a 3.8% price change over the last quarter, following the company's last earnings report in September 2025.
Ticker: ALGEN Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Genoway SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 27 Jul 2026
Value €4,464,782.11 | Price 223.65 | Shares 26,459
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-27 B Purchase
3.6
Alexandre Fraichard

DG

Officer
26,459
223.65
€4,464,782 		26,459 223.65 €4,464,782
2026-07-20 2026-07-16 B Purchase
3.6
Alexandre Fraichard

DG

Officer
9,385
376.68
€1,915,983 		9,385 376.68 €1,915,983
2026-06-22 2026-06-17 S Sale ISTYA FOND DE DOTATION

ADMINISTRATEUR

Director
89,534
299.68
€2,629,592 		89,534 299.68 €2,629,592
2026-06-22 2026-06-17 S Sale SOLYS SARL

ADMINISTRATEUR

Director
4,900
2.40
€11,760 		4,900 2.40 €11,760
2026-06-22 2026-06-17 S Sale CARLYS SOCIETE CIVILE

ADMINISTRATEUR

Director
10,000
2.40
€24,000 		10,000 2.40 €24,000
2026-06-22 2026-05-28 B Purchase SOLYS SARL

ADMINISTRATEUR

Director
5,000
2.40
€12,000 		5,000 2.40 €12,000
2026-05-29 2026-05-28 S Sale
JEAN LOUIS MENARD

ADMINISTRATEUR

Director
4,044
2.40
€9,706 		4,044 2.40 €9,706
2025-12-23 2025-12-17 B Purchase
JEAN LOUIS MENARD

ADMINISTRATEUR

Director
38,500
2.35
€90,475 		38,500 2.35 €90,475
2025-12-19 2025-12-17 B Purchase
2.7
olivier Charmeil

Administrateur Indépendant

Non-Executive Director
42,553
2.35
€100,000 		42,553 2.35 €100,000
2025-04-15 2025-04-11 B Purchase
3.6
Florent Pons

Directeur Marketing

Officer
484
2.80
€1,355 		484 2.80 €1,355
2025-04-15 2025-04-11 B Purchase
3.6
Florent Pons

Directeur Marketing

Officer
516
2.80
€1,445 		516 2.80 €1,445
2025-04-02 2025-03-31 B Purchase
3.6
Alexandre Fraichard

Directeur General

Officer
11,299
3.07
€34,687 		11,299 3.07 €34,687
2025-01-31 2025-01-31 B Purchase
3.6
Alexandre Fraichard

Directeur Général

Officer
12,500
3.04
€38,054 		12,500 3.04 €38,054
2024-09-30 2024-09-25 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
3,880
3.90
€15,132 		3,880 3.90 €15,132
2024-01-18 2024-01-17 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
1,700
4.80
€8,160 		1,700 4.80 €8,160
2023-12-18 2023-12-15 S Sale
3.8
Christian Grenier

Président du CA

Director
5,000
4.40
€22,000 		5,000 4.40 €22,000
2023-11-27 2023-11-23 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
500
4.20
€2,100 		500 4.20 €2,100
2023-10-26 2023-10-23 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
700
3.93
€2,750 		700 3.93 €2,750
2023-10-26 2023-10-23 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
400
3.93
€1,570 		400 3.93 €1,570
2023-09-26 2023-09-25 B Purchase
3.8
Christian Grenier

Pdt Conseil d'administration

Director
5,000
4.00
€20,000 		5,000 4.00 €20,000
Explore more

More insider trading research around Genoway SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe